| API Name |
Systematic (IUPAC) Name |
CAS No |
Therapeutic Area |
| Atorvastatin IP/USP | (3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid | 134523-00-5 | Cardiovascular disease- Treatment of High Cholesterol |
| Ceftibuten IP/USP | "(6R,7R)-7-([(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino) -8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 97519-39-6 | Cephalosporin Antibiotic |
| Celecoxib IP/USP | 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide | 169590-42-5 | Nonsteroidal anti-inflammatory drug (NSAID)- Pain & Inflammation |
| Dobutamine | (RS)-4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol | 34368-04-2 | heart failure and cardiogenic shock |
| Etoricoxib | 5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine | 202409-33-4 | rheumatoid arthritis |
| Fluconazole | 2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol | 86386-73-4 | antifungal medication |
| Glimepiride IP/USP | 3-ethyl-4-methyl-N-(4-[N-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide | 93479-97-1 | Treatment of type 2 diabetes mellitus |
| Heparin Sodium USP | | 9005-49-6 | deep vein thrombosis |
| Ketorolac Tromethamine | (±)-5-benzoyl-2,3-dihydro- 1H-pyrrolizine-1-carboxylic acid, 2-amino-2-(hydroxymethyl)-1,3-propanediol | 74103-06-3 | Nonsteroidal anti-inflammatory drug |
| Lamtrigine | 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine | 84057-84-1 | Anticonvulsants |
| Montelukast IP/USP | (R,E)-2-(1-((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propylthio)methyl)cyclopropyl)acetic acid | 158966-92-8 | Leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies |
| Moxifloxacin | 1-Cyclopropyl-7-[(1S,6S)-2,8-diazabicyclo[4.3.0]nonan-8-yl]-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid | 354812-41-2 | fluoroquinolone antibacterial agent |
| Norfoxacin IP/EP/USP | "1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1H-quinoline-3-carboxylic acid | 70458-96-7 | Chemotherapeutic antibacterial Treatment of urinary tract infections |
| Olmesartan | 5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate | 144689-63-4 | angiotensin II receptor antagonist |
| Pantaprazole | (RS)-6-(Difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzo[d]imidazole | 102625-70-7 | gastroesophageal reflux disease |
| Pregabaline IP/USP | (S)-3-(aminomethyl)-5-methylhexanoic acid | 148553-50-8 | Anticonvulsant and Antiepileptic-drug used for Neuropathic Pain |
| Quitiapine Fumarate | 2-(2-(4-dibenzo[b,f][1,4]thiazepine- 11-yl- 1-piperazinyl)ethoxy)ethanol | 111974-69-7 | atypical antipsychotic |
| Rosuvastatin IP/USP | (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid | 287714-41-4 | Cardiovascular disease- Treatment of High Cholesterol |
| Setraline HCl | (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | 79617-96-2 | Antidepressant |
| Silodosin | 1-(3-hydroxypropyl)-5-[(2R)-({2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]indoline-7-carboxamide | 160970-54-7 | orthostatic hypotension |
| Voglibose | (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol | 83480-29-9 | Diabetes mellitus |
| Zafirlukast IP/USP | cyclopentyl 3-{2-methoxy-4-[(o-tolylsulfonyl)carbamoyl]benzyl}-1-methyl-1H-indol-5-ylcarbamate | 107753-78-6 | Leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies |
Home
Partnership & Alliances
Custom Synthsis
Manufacturing
Products
News
Contact